Journal of Gynecologic Oncology

Aims & Scope

The Journal of Gynecologic Oncology (JGO) is an official publication of the Asian Society of Gynecologic Oncology.

Abbreviated title is 'J Gynecol Oncol'.

It was launched in 1990.

The JGO's aim is to publish the highest quality manuscripts dedicated to the advancement of care of the patients with gynecologic cancer.

It is an international peer-reviewed periodical journal that is published bimonthly (January, March, May, July, September, and November).

Supplement numbers are at times published.

The journal publishes editorials, original and review articles, correspondence, book review, etc.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 1,000.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Advances in diagnosis and treatment of metastatic cervical cancer

  Citation: 374

  Authors: Haoran, Xiaohua, Xi

• FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication

  Citation: 259

  Authors: Jaime

• Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer

  Citation: 181

  Authors: Supachai, Siriwan, Sumonmal, Sunamchok, Thaovalai

• LncRNA XLOC_006390 facilitates cervical cancer tumorigenesis and metastasis as a ceRNA against miR-331-3p and miR-338-3p

  Citation: 155

  Authors: Xiaotian, Yankui

• Epidemiology of gynecologic cancers in China

  Citation: 142

  Authors: Xiyi, Huijuan, Tianhui

• FIGO staging of endometrial cancer: 2023

  Citation: 138

  Authors: Jonathan S., Xavier, Carien, Christina, David, Sean, Kristina, David, Nicole

• Clinical characteristics of struma ovarii

  Citation: 135

  Authors: Seung-Chul, Ki-Hong, Mi-Ok, Suk-Joon, Hee-Sug, Haeng-Soo

• Clinical statistics of gynecologic cancers in Japan

  Citation: 135

  Authors: Wataru, Satoru, Fumiaki, Kazuhiko, Toru, Daisuke, Hidetaka

• Randomized study between radical surgery and radiotherapy for the treatment of stage IB–IIA cervical cancer: 20-year update

  Citation: 131

  Authors: Fabio, Alessandro, Rodolfo, Franco, Vanna, Costantino

• Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism

  Citation: 118

  Authors: Shan-Shan, Jing, Alice S. T.